Back to Authors

Blair, Janis E.

https://orcid.org/0000-0003-2267-1473

Mayo Clinic

Mayo Clinic in Arizona

Citations 79

Approach to Management of Coccidioidomycosis in Patients Receiving Inhibitors of Tumor Necrosis Factor-α
Blair, Janis E. , Wack, Elizabeth E., Mertz, Lester E., Galgiani, John N.

Infectious Diseases in Clinical Practice | November 9, 2016 | Volume: 25 | Issue: 4 | Pages: 184-192

10.1097/ipc.0000000000000466 Get It

Abstract Inhibitors of tumor necrosis factor-α (TNFIs) have revolutionized the treatment for patients with a variety of inflammatory illnesses, including rheumatoid arthritis, psoriasis and psoriatic arthritis, ankylosing spondylitis, and other inflammatory diseases, and have improved the outcomes and quality of life for such patients. Endemic fungal infections, such as coccidioidomycosis, are observed to occur in persons who are treated with these agents and who live in the Coccidioides-endemic area with similar frequency as persons in the general, healthy public but with an increased likelihood of symptomatic infection and extrapulmonary dissemination. Because the control of coccidioidal infections requires the formation and maintenance of granuloma, it is not unexpected that TNFIs, which inhibit granuloma formation, seem to increase the risk of clinical disease. No guidelines exist to address the prevention and management of disease in patients whose treatment course with TNFIs is complicated by subclinical or clinical coccidioidal infection. Therefore, we reviewed the available medical literature and offer suggestions to the approach and treatment of patients with various forms of coccidioidomycosis before and during therapy with TNFIs.
Integrative Medicine Preferences Among Coccidioidomycosis (Valley Fever) Patients
Short, Jack H., Bradley, Constance, Blair, Janis E. , Stewart, Terry D., Burns, Mark W. , Patron, Roberto L. , Millstine, Denise , Millstine, Denise M

The Journal of Alternative and Complementary Medicine: Paradigm, Practice, and Policy Advancing Integrative Health | August 24, 2016 | Volume: 23 | Issue: 2 | Pages: 135-139

10.1089/acm.2016.0139 Get It

Objectives: To understand the extent and modalities of integrative medicine strategies that patients with coccidioidomycosis (valley fever) have incorporated into their treatment regimens. Design: A direct patient survey was distributed, with 100 unique responses, at a single infectious diseases clinic at an academic medical center in Arizona. Eligible patients, defined as those with confirmed coccidioidomycosis or currently under evaluation, were polled on their personal use of 36 integrative medicine modalities. Patients were also asked to indicate their level of fatigue on a 10-point scale in an attempt to correlate levels of fatigue to use of specific integrative medicine modalities. Results: Of the patients surveyed, 64% had used at least one integrative medicine modality, and 53% used two or more, along with conventional medical therapy. The top three modalities were nutrition (39%), massage (27%), and breathing exercises (26%). The mean reported fatigue level was 4.7 on a 10-point scale, with a standard deviation of 3.0. There was no statistically significant association between use of a specific modality and reported level of fatigue. Conclusions: Nearly two thirds of patients (64%) surveyed had used at least one integrative medicine modality throughout the course of their therapy. Clinicians are probably unaware of the extent to which many patients, including this population, have embraced integrative medicine. Awareness of patients' goal and preferences is valuable in shared clinical decision making.
Executive Summary: 2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
Galgiani, John N. , Ampel, Neil M. , Blair, Janis E. , Catanzaro, Antonino , Geertsma, Francesca, Hoover, Susan E. , Johnson, Royce H. , Kusne, Shimon , Lisse, Jeffrey , MacDonald, Joel D., Meyerson, Shari L. , Raksin, P B , Siever, John, Stevens, David A. , Sunenshine, Rebecca, Siever, John, Theodore, Nicholas

Clinical Infectious Diseases | August 24, 2016 | Volume: 63 | Issue: 6 | Pages: 717-722

10.1093/cid/ciw538 Get It

Abstract It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. Infectious Diseases Society of America considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances. Coccidioidomycosis, also known as San Joaquin Valley fever, is a systemic infection endemic to parts of the southwestern United States and elsewhere in the Western Hemisphere. Residence in and recent travel to these areas are critical elements for the accurate recognition of patients who develop this infection. In this practice guideline, we have organized our recommendations to address actionable questions concerning the entire spectrum of clinical syndromes. These can range from initial pulmonary infection, which eventually resolves whether or not antifungal therapy is administered, to a variety of pulmonary and extrapulmonary complications. Additional recommendations address management of coccidioidomycosis occurring for special at-risk populations. Finally, preemptive management strategies are outlined in certain at-risk populations and after unintentional laboratory exposure.
Total and Lectin-Binding Proteome of Spherulin from Coccidioides posadasii
Grys, Thomas E. , Kaushal, Setu, Chowdhury, Yasmynn, Dasari, Surendra , Mitchell, Natalie M., Magee, D. Mitchell, Blair, Janis E. , Colby, Thomas V. , Lake, Douglas F. , Mitchell, Natalie Michelle, Grys, Thomas E

Journal of Proteome Research | August 22, 2016 | Volume: 15 | Issue: 10 | Pages: 3463-3472

10.1021/acs.jproteome.5b01054 Get It

2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
Galgiani, John N. , Ampel, Neil M. , Blair, Janis E. , Catanzaro, Antonino , Geertsma, Francesca, Hoover, Susan E. , Johnson, Royce H. , Kusne, Shimon , Lisse, Jeffrey , MacDonald, Joel D., Meyerson, Shari L. , Raksin, P B , Siever, John, Stevens, David A. , Sunenshine, Rebecca, Siever, John, Theodore, Nicholas

Clinical Infectious Diseases | July 28, 2016 | Volume: 63 | Issue: 6 | Pages: e112-e146

10.1093/cid/ciw360 Get It

Abstract It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. Infectious Diseases Society of America considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances. Coccidioidomycosis, also known as San Joaquin Valley fever, is a systemic infection endemic to parts of the southwestern United States and elsewhere in the Western Hemisphere. Residence in and recent travel to these areas are critical elements for the accurate recognition of patients who develop this infection. In this practice guideline, we have organized our recommendations to address actionable questions concerning the entire spectrum of clinical syndromes. These can range from initial pulmonary infection, which eventually resolves whether or not antifungal therapy is administered, to a variety of pulmonary and extrapulmonary complications. Additional recommendations address management of coccidioidomycosis occurring for special at-risk populations. Finally, preemptive management strategies are outlined in certain at-risk populations and after unintentional laboratory exposure.
Introducing routine HIV screening for patients on an internal medicine residency inpatient service: a quality improvement project
Padrnos, Leslie , Barr, Patrick J, Klassen, Christine L. , Fields, Heather , Azadeh, Natalya , Mendoza, N. S., Pauwels, Emanuel M, King, Christopher S. , Chung, Andrew A., Sakata, Kenneth K. , Blair, Janis E. , Padrnos, Leslie J, Fields, Heather E, Mendoza, Neil, Saadiq, Rayya A. , Mendoza, N. S.

BMJ Quality Improvement Reports | May 5, 2016 | Volume: 5 | Issue: 1 | Pages: u206955.w3030

10.1136/bmjquality.u206955.w3030 Get It

The US Centers for Disease Control and Prevention (CDC) recommend human immunodeficiency virus (HIV) screening for all persons aged 13 to 64 years who present to a health care provider. We sought to improve adherence to the CDC guidelines on the Internal Medicine Resident Hospital Service. We surveyed residents about the CDC guidelines, sent email reminders, provided education, and engaged them in friendly competition. Credit for guideline adherence was awarded if an offer of HIV screening was documented at admission, if a screening test was performed, or if a notation in the resident sign out sheet indicated why screening was not performed. We examined HIV screening of a postintervention group of patients admitted between August 8, 2012, and June 30, 2013, and compared them to a preintervention group admitted between August 1, 2011, and June 30, 2012. Postintervention offers of HIV screening increased significantly (7.9% [44/559] vs 55.5% [300/541]; P<.001), as did documentation of residents' contemplation of screening (8.9% [50/559] vs 67.5% [365/541]; P<.001). A significantly higher proportion of HIV screening tests was ordered postintervention (7.7% [43/559] vs 44.4% [240/541]; P<.001). Monthly HIV screening documentation ranged from 0% (0/53) to 17% (9/53) preintervention, whereas it ranged from 30.6% (11/36) to 100% (62/62) postintervention. HIV screening adherence can be improved through resident education, friendly competition, and system reminders. Barriers to achieving sustained adherence to the CDC guidelines include a heterogeneous patient population and provider discomfort with the subject.
Pregnancy and Parental Leave During Graduate Medical Education
Blair, Janis E. , Mayer, Anita P. , Caubet, Suzanne L., Norby, Suzanne M. , O’Connor, Mary I. , Hayes, Sharonne N.

Academic Medicine | November 25, 2015 | Volume: 91 | Issue: 7 | Pages: 972-978

10.1097/acm.0000000000001006 Get It

Purpose To understand the pregnancy, childbirth, and parental leave plans and experiences of trainees in multiple graduate medical education (GME) programs at a single institution. Method In 2013, the authors developed and deployed a voluntary, Internet-based survey of trainees in 269 residency and fellowship programs across the three sites of the Mayo School of Graduate Medical Education. The survey assessed pregnancy-related issues, including use of relevant institutional policies, changes in work due to pregnancy, and activities during pregnancy and parental leave. The authors analyzed the responses to make comparisons across groups. Results Forty-two percent (644/1,516) of trainees responded. Less than half (264; 41%) had children, and 46 (7%) were currently pregnant (themselves or their partners). Among parents, 24 (of 73; 33%) women and 28 (of 81; 35%) men planned to have another child during their current training program, and 13 (18%) women and 14 (17%) men planned to do so during their next training program. Among nonparents, 40 (of 135; 30%) women and 36 (of 111; 32%) men planned pregnancies during their current training program, and 25 (19%) women and 14 (13%) men planned pregnancies during their next training program. Of respondents eligible for parental leave, 81 (of 83; 98%) women and 89 (of 101; 88%) men had used it. Conclusions Approximately 40% of respondents planned to have children during their GME training; most will require family leave and institutional support. GME programs should pursue policies and practices to minimize the effects of these leaves on their workforce.
Chronic interstitial granulomatous dermatitis in coccidioidomycosis
Mangold, Aaron R. , DiCaudo, David J. , Blair, Janis E. , Sekulić, Aleksandar , Mangold, A R

British Journal of Dermatology | November 17, 2015 | Volume: 174 | Issue: 4 | Pages: 881-884

10.1111/bjd.14295 Get It

Videoconference Interviewing: Tips for Success
Williams, Kathryn , Kling, Juliana M. , Labonte, Helene R., Blair, Janis E. , Kling, Juliana M

Journal of Graduate Medical Education | September 1, 2015 | Volume: 7 | Issue: 3 | Pages: 331-333

10.4300/jgme-d-14-00507.1 Get It

Diagnosis, treatment, and outcomes of coccidioidomycosis in allogeneic stem cell transplantation
Mendoza, Neil, Noël, Pierre, Blair, Janis E.

Transplant Infectious Disease | February 14, 2015 | Volume: 17 | Issue: 3 | Pages: 380-388

10.1111/tid.12372 Get It

AbstractBackgroundAllogeneic hematopoietic stem cell transplant (allo‐HSCT) recipients have multiple risk factors for coccidioidomycosis, and previous reports of coccidioidomycosis in this patient population describe severe infections with poor outcomes.MethodsWe performed a retrospective chart review of allo‐HSCT recipients with active coccidioidomycosis to characterize the utility of diagnostic tests for coccidioidomycosis and to determine treatment outcomes.ResultsEleven of 426 (2.6%) allo‐HSCT recipients experienced active coccidioidomycosis after transplantation. Of these 11 patients, 1 (9%) had extrapulmonary infection, 9 (82%) patients were hospitalized, and 5 (45%) died. Culture or histology was positive in 33% (3/9) of the patients tested. Most (64% [7/11]) had at least 1 positive serologic test result, and the enzyme immunoassay immunoglobulin G test was positive most often (overall 55% [6/11]). Chest radiographs and chest computed tomography scans showed miliary or multifocal nodular infiltrates or consolidations, consistent with coccidioidomycosis, in 80% (8/10) and 100% (9/9), respectively, of patients tested throughout the course of active illness. Rapid polymerase chain reaction testing was positive in 71% (5/7) of the patients tested. Peripheral eosinophilia was present in 18% (2/11) of patients.ConclusionCoccidioidomycosis is associated with high morbidity and mortality in allo‐HSCT recipients in an area endemic for Coccidioides. Diagnosis of this infection can be difficult and often requires multiple and frequently invasive tests. Antifungal prophylaxis should be considered for patients at highest risk.